Gene polymorphisms are a common genetic variant. The most common polymorphic form is a base difference, termed a single nucleotide polymorphism (SNP). Approximately 50% of SNPs occur in the noncoding region of a gene. MicroRNAs (miRNAs) are single stranded, 18--23 nucleotide-long, RNA molecules, which can be polymorphic and can affect maturation and function of the miRNA, possibly resulting in disease. For example, the pri-miR-15a/miR-16 C/T polymorphism is associated with familial chronic lymphocytic leukemia[@b1]; pri-miR-218 rs11134527 is associated with the risk of liver cancer in the Chinese population[@b2]; pri-miR-185 rs2008591 is associated with the risk of breast cancer[@b3]; pre-miR-423 rs6505162 and pre-miR-608 rs4919510 are associated with the prognosis of colorectal cancer[@b4]; miR-146a G/C and pri-let-7a-2 rs629367 are associated with the prognosis of gastric cancer[@b5][@b6]; pre-miR-196a2 rs11614913 and pre-miR-146a rs2910164 are associated with the prognosis of non-small cell lung cancer[@b7][@b8]; and pre-miR-146a rs2910164 is associated with the prognosis of adult gliomas[@b9]. Although there are some studies on the association of the risk and prognosis of cancer with single polymorphic miRNAs, there are few reports on the relationship between target gene-based miRNA polymorphisms and cancer. MiRNAs cause mRNA degradation or translational containment through complete or incomplete complementarity with the 3′ non-coding sequence of its target gene[@b10]. Polymorphic miRNAs can affect the process of miRNA maturation, and then affect its regulatory function on the target gene[@b1][@b2][@b3]. Single miRNAs can regulate different genes and multiple miRNAs can be regulated by the same target gene. The exploration of the relationship between targeted gene-based miRNA polymorphisms and cancer would be helpful to discover the potential of miRNA target gene-related diseases. It would also be helpful to clarify the role of miRNA genetic variation and its target gene dysregulation in cancer development, including determining the molecular pathways of miRNAs involved in target gene regulation.

Pepsinogen C (encoded by *PGC*) is the mature form of an aspartic proteinase present in the gastric mucosa and serum, and is used in a serological test for early screening of gastric cancer and precancerous disease. Our previous studies in normal gastric mucosa, atrophic gastritis (precancerous disease group) and the gastric disease chain showed that PGC protein levels decrease gradually with disease progression[@b11]. The serological detection of PGC can be used to evaluate and manage the advance of gastric cancer and precancerous diseases[@b12]. However, the regulation of the PGC protein levels is not clear.

Previously, we used the NCBI bioinformatics database to predict miRNAs that might target *PGC*, and identified let-7e, miR-4795 and miR-365b, which were confirmed by luciferase reporter experiments. According to the screening rule that a polymorphic locus in the Chinese population should exist with a frequency distribution and minor allele frequency (MAF) \> 5, we screened three tagSNPs (SNPs that uniquely represent a haplotype) located in the primary precursor regions of the three miRNAs. They were, pri-let-7e rs8111742, located in the let-7e gene promoter region at −565 bp; pri-miR-365b rs121224, located in the miR-365b gene promoter region at −430 bp; and pri-miR-4795 rs1002765, located in pri-miR-4795 gene promoter region at −1635 bp. These three tagSNPs are all located in important promoter regions. Whether these miRNA SNPs are associated with the downregulation of *PGC* in atrophic gastritis or gastric cancer; whether they can be used as diagnostic or prognostic markers of gastric cancer; and what are the relationships between miRNA polymorphisms and *Helicobacter pylori* infection, smoking and alcohol consumption, as well as other gastric cancer environmental factors, remain unclear.

This case-control study aimed to explore the relationships between polymorphisms in the *PGC*-targeting miRNAs, pri-let-7e, pri-miR-365b, pri-miR-4795, with the risk and prognosis of atrophy gastritis and gastric cancer in a northern Chinese population to explore their potential as specific markers of gastric cancer and its precursor. This study could provide a theoretical and experimental basis for further exploration of the genetic variation of these three miRNAs and the dysregulation of their target gene, *PGC*, in gastric cancer development.

Results
=======

Subject information
-------------------

The study subjects included 862 patients with atrophic gastritis, 724 with gastric cancer and 862 control subjects. There was no significant difference in the age or sex distribution between the gastric cancer group and the control group or between the atrophic gastritis group and the control group. The characteristics of the three groups are shown in [Table 1](#t1){ref-type="table"}. We selected 357 subjects who underwent surgical treatment and were subjected to regular follow-up. The prognosis of gastric cancer patients with complete clinical pathology data was studied. Clinical staging of gastric cancer used the seventh edition of the UICC TNM staging[@b13], and Lauren typing[@b14] was used for the histological classification of gastric cancer ([Table 1](#t1){ref-type="table"}).

Association of pri-let-7e rs8111742, pri-miR-365b rs121224 and pri-miR-4795 rs1002765 with risk of atrophic gastritis and gastric cancer
----------------------------------------------------------------------------------------------------------------------------------------

The overall analysis of all cases showed no significant correlations for the three miRNA polymorphisms with the risk of atrophic gastritis or gastric cancer ([Table 2](#t2){ref-type="table"}).

Stratified analysis of pri-let-7e rs8111742, pri-miR-365b rs121224 and pri-miR-4795 rs1002765 and risk of atrophic gastritis and gastric cancer
-----------------------------------------------------------------------------------------------------------------------------------------------

We further analyzed environmental factors such as *H. pylori* infection, smoking and alcohol consumption, and found that the let-7e rs8111742 AA genotype could increase the risk of gastric cancer (*P* = 0.044) in the *H. pylori*-positive group, while the miR-4795 rs1002765 AA genotype could reduce the risk of gastric cancer (*P* = 0.050) in the *H. pylori*-positive group ([Table 3](#t3){ref-type="table"}).

Associations of pri-let-7e rs8111742, pri-miR-365b rs121224 and pri-miR-4795 rs1002765 with the risk of intestinal-type and diffuse-type gastric cancer
-------------------------------------------------------------------------------------------------------------------------------------------------------

By Lauren typing, we divided the gastric cancer patients into intestinal-type and diffuse-type. The associations of the three miRNA polymorphisms with the risk of intestinal-type and diffuse-type gastric cancer were then analyzed. There were no significant correlations between any of the miRNA polymorphisms and the risk of either gastric cancer ([Table 4](#t4){ref-type="table"}). Further analysis of environmental factors, such as *H. pylori* infection, smoking and alcohol consumption, found that in the alcohol consumption subgroup, the pri-miR-365b rs121224 GG genotype could increase the risk of intestinal-type gastric cancer compared with the CC genotype (*P* = 0.029) and the CG + CC genotype (*P* = 0.045), respectively. For the pri-miR-4795 rs1002765 polymorphism, the GA + AA genotype could reduce the risk of diffuse-type gastric cancer compared with the GG genotype (*P* = 0.032). The pri-miR-4795 rs1002765 AA genotype could reduce the risk of diffuse-type gastric cancer in the *H. pylori* infection-positive subgroup compared with the GG and GA + GG genotypes (*P* = 0.005, respectively) ([Table 5](#t5){ref-type="table"}).

Correlation of pri-let-7e rs8111742, pri-miR-365b rs121224 and pri-miR-4795 rs1002765 with clinical pathological parameters
---------------------------------------------------------------------------------------------------------------------------

MiR-365b rs121224 was related to Lauren and TNM staging. In contrast with diffuse-type gastric cancer or the TNM III-IV stage subgroup, the distribution frequency of GG genotype carriers in the intestinal-type gastric cancer subgroup and in the TNM I-II stage subgroup was higher than that of the CG + CC genotype carriers (*P* = 0.014, *P* = 0.031 respectively) ([Table 6](#t6){ref-type="table"}).

Association of pri-let-7e rs8111742, pri-miR-365b rs121224 and pri-miR-4795 rs1002765 with gastric cancer prognosis
-------------------------------------------------------------------------------------------------------------------

The miR-365b rs121224 GG genotype was associated with a better prognosis compared with the CG or CC genotypes in the Borrmann III-IV subgroup and in the intestinal-type gastric cancer subgroup (*P* = 0.042, *P* = 0.031, respectively) ([Table 7](#t7){ref-type="table"}).

Discussion
==========

This paper explored the associations of polymorphisms in three miRNAs (let-7e rs8111742 G \> A, miR-365b rs121224 C \> G and miR-4795 rs1002765 G \> A) that target *PGC* with the risk and prognosis of gastric cancer and atrophic gastritis. Overall risk analysis revealed that there was no significant correlation between the three miRNA polymorphisms and gastric cancer or atrophic gastritis. However, subgroup analysis revealed that let-7e rs8111742 and miR-4795 rs1002765 were associated with the risk of gastric cancer in the *H. pylori*-positive subgroup. MiR-365b rs121224 was associated with intestinal-type gastric cancer risk in the alcohol consumption subgroup, and miR-4795 rs1002765 was associated with diffuse-type gastric cancer risk in the *H. pylori*-positive and alcohol consumption subgroups. Prognostic analysis revealed that intestinal-type gastric cancer patients at Borrmann stage III-IV who carry miR-365b rs121224 GG genotype have a better prognosis compared with those who carry the CG or CC genotypes. MiR-365b rs121224 was associated with Lauren typing and TNM staging, in which the distribution of GG genotype carriers in intestinal-type gastric cancer and the TNM stage I-II subgroup was higher than that of CG or CC genotypes, which is in contrast with the distribution in diffuse-type gastric cancer or TNM III-IV groups. To the best of our knowledge this is the first study to report on the association of three miRNA tagSNPs that target *PGC* with the risk and prognosis of gastric cancer and atrophic gastritis in a Chinese population.

MiRNA polymorphisms may be associated with susceptibility to disease[@b15]. Certain miRNA polymorphisms are associated with the overall population risk, some of which are associated with risk in a specific population. In this study, we did not find that let-7e rs8111742 G \> A, miR-365b rs121224 C \> G and miR-4795 rs1002765 G \> A are associated with gastric cancer and atrophic gastritis risk in the general population. However, in the subgroup analysis, it was found that the three miRNA polymorphisms were related to a specific population who are infected with *H. pylori* or who consume alcohol. *H. pylori* is one of the most important environmental factors in the stomach, and the development of intestinal-type gastric cancer and diffuse-type gastric cancer are related to *H. pylori* infection[@b11]. This study found that the let-7e rs8111742 and miR-4795 rs1002765 polymorphisms increased and decreased, respectively, the risk of gastric cancer in the *H. pylori*-positive subgroup. This indicated that the let-7e mutation might be a risk genotype, which might have a positive effect on the occurrence and development of gastric cancer, and that the miR-4795 mutation may play a protective role in the development of gastric cancer. Furthermore, *H. pylori* may be an intermediary or bridge that mediates host gene polymorphisms and susceptibility to gastric cancer. Although there are no other reports on the relationship between these two polymorphisms and disease, studies have found that other miRNA polymorphisms are associated with gastric disease in *H. pylori* infected patients. For example, the interaction between *H. pylori* and the TLR4 gene and miR-146a polymorphisms has been studied. It was found that the combined effect of the miR-146a rs2910164 GG genotype and the TLR4 + 3725C allele could increase the risk of severe atrophic gastritis in a Japanese population infected with *H. pylori*[@b16]. In addition, Song *et al*. found that in an *H. pylori*-positive subgroup, the miR-146a rs2910164 C allele increased the risk of intestinal metaplasia and dysplasia[@b17]. Okubo *et al*. found that the rs11614913 TT polymorphism in miR-196a-2 correlated positively with the degree of induced monocyte infiltration in *H. pylori* infection[@b18]. These findings suggest that a high risk miRNA polymorphism carrier with *H. pylori* infection is at higher risk of suffering from gastric cancer and precancerous disease; therefore, more attention should be paid to their follow-up and to individual prevention. Similarly, our study found that miR-365b rs121224 was associated with intestinal-type gastric cancer risk in the alcohol consumption subgroup, and miR-4795 rs1002765 was associated with diffuse-type gastric cancer risk in the *H. pylori*-positive and alcohol consumption subgroup. Thus, a high risk miRNA polymorphism carrier that drinks alcohol also has a potential risk of suffering from gastric cancer and precancerous disease, and should be vigilant.

In the prognosis analysis, we found that the GG genotype of miR-365b rs121224 was associated with better prognosis in the Borrmann III-IV and intestinal-type gastric cancer subgroups. There are two copies of the miR-365 gene in the human genome. MiR-365a is located on chromosome 16 and miR-365b is on chromosome 17; however, they both produce the same mature miR-365. The rs121224 polymorphism is located 430 bp upstream of miR-365b in the promoter region. The biological function of miR-365 is uncertain. Some scholars believe that miR-365 is an "oncogene". It is expressed at high levels in skin squamous cell carcinoma and in some cancer cell lines, and *in vivo* experiments confirmed that over-expression of mir-365 can promote subcutaneous tumors in mice[@b19]. Furthermore, inhibition of mir-365 expression can cause cells to arrest in G1 phase and undergo apoptosis, thus inhibiting the formation of skin tumors[@b20][@b21]. However, in recent years, mir-365 has been shown to inhibit cancer. It is downregulated in lung cancer tissues; inhibits tumor cell line migration[@b22][@b23][@b24][@b25][@b26][@b27]; and promotes apoptosis and regulates bcl-2 expression[@b23][@b24]. The results of this study showed that the risk of intestinal-type gastric cancer in the alcohol consumption subgroup was lower with the pri-miR-365b rs121224 C allele, but that the subgroup of patients with Borrmann type III-IV staging had a better prognosis with the G genotype. The transcription factors Sp1 and NF-κB are associated with the promoter region of miR-365 and they activate cellular signaling pathways[@b22]; therefore, the genotype of rs121224 may affect the involvement of miR-365 in cell signaling pathways. Upregulation of miR-365 can also lead to changes in the Akt/PTEN/p53 pathway, with downregulation of PTEN protein levels[@b27] leading to the accumulation of alcohol in cells[@b28]. Thus, the polymorphism in the miR-365 promoter region may be involved in the pathogenesis of intestinal-type gastric cancer by altering cell signaling. SNP rs121224 is located in the precursor region of pri-miR-365b and can affect the expression level and maturation process of the miRNA, which may affect its function. We hypothesized that the rs121224 polymorphism in the promoter region might be associated with decreased binding capacity of miR-365 transcription factors (Sp1 and NF-κB) and thus it is not able to stimulate cell proliferation via the MAPK pathway; thus the carriers have better prognosis. In gastric cancer progression, we found that the frequency of rs121224 GG genotype carriers in the intestinal-type gastric cancer subgroup and the TNM stage I-II subgroup was significantly higher than that of CG + CC carriers, which is consistent with the Borrmann type III-IV stage subgroup of patients, who had better prognosis with the G genotype.

MiRNAs let-7e, miR-4795 and miR-365b all target PGC. As we know PGC is a product of terminally differentiated gastric mucosa. The expression of PGC protein decreased gradually with gastric disease progression[@b11]. Our previous studies showed that a *PGC* polymorphism was also associated with gastric cancer and atrophic gastritis[@b29][@b30][@b31]. It is well accepted that gene--gene interactions are more important than single genes in promoting cancer susceptibility[@b32][@b33][@b34]. For example, gene polymorphisms that individually have a weak effect can have a strong effect when acting in synergy[@b35]. Similarly, the epistatic effect, which is a phenomenon that consists of the effect of complex interactions, is greater than the main effects of any single susceptibility gene[@b31][@b34]. The latest research in our group found that when these three miRNA polymorphisms and their target gene PGC polymorphisms are present together, epistasis occurs and the SNP--SNP interaction between the three miRNAs and their target *PGC* can increase the prediction risk of atrophic gastritis from 1.49 to 6.95 times[@b36]. Beside epistatic effect, it should be noted that miRNAs can affect the expression of its target genes by binding to 3′UTR regions. Thus, genetic variation of miRNA may be involved in the regulation of its target gene expression. Several studies have demonstrated that a variety of miRNAs may bind with PGC and affect its expression. For example, Liu *et al*. reported that serum let-7 microRNA negatively regulated the expression of PGC gene[@b37]. Other scholars suggested that miR-27a rs895819 polymorphism could affect the expression of its targeted gene ZBTB10[@b38]. And the promoter polymorphism of miR-34b/c rs4938723 could influence the transcription activity of miR-34b/c promoter, which therefore affect miRNA expression[@b39][@b40]. As the three described polymorphisms of let-7e, miR-4795 and miR-365b are all located in the important promoter regions, we speculate that these miRNA SNPs may be associated with the downregulation of PGC expression, thus increasing gastric cancer risk. Further study would be warranted to verify our assumptions and determine the molecular pathways of the miRNA polymorphisms involved in the regulation of the targeted PGC gene.

Several limitations of our study should be noted. First, the number of cases needs to be expanded to enable a stratified analysis. Second, data from other environmental factors, such as diet, should be analyzed. Third, functional studies are needed to determine the pathogenic pathways in which the miRNA polymorphisms operate.

In summary, we performed a case-control study to explore the associations of polymorphisms in three miRNAs that target *PGC* with the risk and prognosis of gastric cancer/atrophic gastritis. We found that pri-let-7e rs8111742 in the *H. pylori* infection-positive subgroup was associated with the risk of gastric cancer and that miR-4795 rs1002765 in the *H. pylori* infection-positive and alcohol consumption subgroups was associated with diffuse-type gastric cancer. Pri-miR-365b rs121224 is associated with intestinal-type gastric cancer in the alcohol consumption subgroup, and the G allele was found to have a better prognosis in patients with Borrmann III--IV staging and intestinal-type gastric cancer. These findings suggest that these miRNA polymorphisms may be markers for gastric cancer risk and prognosis, especially related to specific populations infected with *H. pylori* or who consume alcohol. This study also provided an experimental basis for further study of the regulation of PGC in the pathogenesis of gastric cancer.

Materials and Methods
=====================

Patients
--------

This study was approved by the ethics committee of the First Affiliated Hospital of China Medical University. Written informed consent was obtained from all participants. We confirm that all experiments were performed in accordance with relevant guidelines and regulations. We enrolled 2448 subjects, including 862 atrophic gastritis, 724 gastric cancer and 862 control cases. The control group and atrophic gastritis group were all selected from the Zhuanghe Gastric Diseases Screening Program, which has been previously reported[@b12]. Fasting venous blood and biopsies were collected from subjects and histopathological diagnosis performed. The control group was confirmed to be normal or to have mild superficial gastritis by microscopic examination. Sydney classification[@b41][@b42] was used to confirm atrophic gastritis, and patients with moderate to severe atrophic gastritis were selected for the atrophic gastritis group. Gastric cancer cases were all patients attending the First Affiliated Hospital of China Medical University. After admission, endoscopic biopsy and tissue pathology diagnosis were carried out. Patient data (including age, gender, smoking and drinking habits) were recorded and have been published previously[@b29]. For the prognosis study, we selected subjects who underwent surgical treatment and were subjected to regular follow-up; ultimately, 357 gastric cancer patients with complete clinical pathology data were studied. The clinical staging of gastric cancer used the seventh edition of UICC TNM staging[@b13], and Lauren typing[@b14] was used for the histological classification of gastric cancer.

Subject's genotyping
--------------------

DNA was extracted from the patients' venous blood, and Sequenom's MassArray system was used to conduct polymorphism typing in all cases[@b29]. Repeated verification (Sequenom's MassArray system) was performed for 10% of cases and the repetition rate was \>99%.

The determination of serum Helicobacter pylori -IgG titer
---------------------------------------------------------

The serum *H. pylori*-IgG titer was detected using an enzyme-linked immunosorbent assay (Helicobacter pylori IgG kit; Biohit, Helsinki, Finland) according to a previously described method[@b5][@b43]. Patients with a serum titer \>34 IU were diagnosed as *H. pylori* positive.

Statistics
----------

The dominant model compared heterozygotes and homozygous mutant with wild-types and the recessive model compared homozygous mutants with wild-types and heterozygotes. The distribution of demographic characteristics in the case and control groups, and the frequency distribution of genotypes in the disease group were measured using the χ^2^ test, and Student's t test was used to assess age and other data. *P* \< 0.05 was considered statistically significant.
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###### The basic information of the research subjects for the risk and prognosis studies.

  Variables                    For the risk study   For the prognosis study                                                                                           
  --------------------------- -------------------- ------------------------- ----------------- ----------------- --------- -------- --------------------------------- ----------------
                                **n** = **862**         **N** = **862**       **n** = **729**   **n** = **724**   n = 357   n = 89                                            
  Gender                          *P* = 0.846             *P* = 0.564                                                                                                 
   Male                            483(56.0)               487(56.5)             483(66.3)         490(67.7)        255       63     60.8[a](#t1-fn1){ref-type="fn"}       0.797
   Female                          379(44.0)               375(43.5)             246(33.7)         234(32.3)        102       26     45.7[a](#t1-fn1){ref-type="fn"}          
  Age                             *P* = 0.343                                   *P* = 0.562                                                                                   
   Mean ± SD                       54.9 ± 9.2             55.4 ± 9.5            56.1 ± 9.2        56.4 ± 9.8         /        /                     /                         
   Median                              54                     56                    56                57             /        /                     /                         
   Range                             17--85                 16--79                17--85            21--81           /        /                     /                         
  *H. pylori*                     *P* \< 0.001                                 *P* \< 0.001                                                                                   
   Positive                        241(28.0)               505(58.6)             201(27.6)         369(51.0)         /        /                     /                         
   Negative                        621(72.0)              41.4(36.5)             528(72.4)         355(49.0)         /        /                     /                         
  Smoking                       **n** = **586**         **N** = **548**       **n** = **500**   **n** = **333**                                                               
                                  *P* = 0.299             *P* = 0.183                                                                                                 
   Ever Smoker                     202(34.5)               173(31.6)             199(39.8)         148(44.4)         /        /                     /                         
   Never Smoker                    384(65.5)               375(68.4)             301(60.2)         185(55.6)         /        /                     /                         
  Drinking                      **n** = **585**         **N** = **547**       **n** = **499**   **n** = **296**                                                               
                                  *P* = 0.333             *P* = 0.044                                                                                                 
   Drinker                         147(25.1)               124(22.7)             146(29.3)         107(36.1)         /        /                     /                         
   Nondrinker                      438(74.9)               423(77.3)             353(70.7)         189(63.9)         /        /                     /                         
  Borrmann type                                                                                                                                                            0.055
   Borrmann I--II                      /                       /                     /                 /            83        23     66.5[a](#t1-fn1){ref-type="fn"}          
   Borrmann III--IV                    /                       /                     /                 /            274       66     53.8[a](#t1-fn1){ref-type="fn"}          
  Lauren type                                                                                                                                                              0.234
   Intestinal type                     /                       /                     /                 /            120       25     59.9[a](#t1-fn1){ref-type="fn"}          
   Diffuse type                        /                       /                     /                 /            231       61     59.3[a](#t1-fn1){ref-type="fn"}          
   Non classified carcinoma            /                       /                     /                 /             6                                                        
  TNM stage                                                                                                                                                            9.40 × 10^−15^
   I--II                               /                       /                     /                 /            171       12                  73.5a                       
   III--IV                             /                       /                     /                 /            186       77                   27                         
  Depth of invasion                                                                                                                                                    5.35 × 10^−9^
   T1 + T2                             /                       /                     /                 /            98        3      76.8[a](#t1-fn1){ref-type="fn"}          
   T3 + T4                             /                       /                     /                 /            259       86     52.2[a](#t1-fn1){ref-type="fn"}          
  Lymph node metastasis                                                                                                                                                1.82 × 10^−8^
   positive                            /                       /                     /                 /            216       77                   32                         
   negtive                             /                       /                     /                 /            141       12     71.5[a](#t1-fn1){ref-type="fn"}          

^a^Mean survival time was provided when MST could not be calculated.

###### Relationship between pri-let-7e rs8111742, pri-miR-365b rs121224, pri-miR-4795 rs1002765 and risk of atrophic gastritis and gastric cancer.

                               Control group (%)   Atrophic gastritis group (%)   Atrophic gastritis group vs. control group   Control group (%)   Cancer group (%)   Cancer group vs. control group          
  --------------------------- ------------------- ------------------------------ -------------------------------------------- ------------------- ------------------ -------------------------------- ------- ------------------
                                    n = 862                  n = 862                                                                                   n = 729                   n = 724                               
  **pri-let7e rs8111742**                                                                                                                                                                                     
   GG                              459(53.2)                458(53.1)                                                                1.00             389(53.4)                 375(51.8)                            1.00
   GA                              341(39.6)                343(39.8)                               0.921                      1.01(0.82--1.25)       285(39.1)                 291(40.2)              0.690   1.05(0.84--1.31)
   AA                               62(7.2)                  61(7.1)                                0.987                      1.00(0.67--1.48)        55(7.5)                   58(8.0)               0.795   1.06(0.70--1.59)
   AA + GA vs. GG                                                                                   0.927                      1.01(0.83--1.23)                                                        0.667   1.05(0.85--1.30)
   AA vs. GA + GG                                                                                   0.984                      1.00(0.68--1.47)                                                        0.854   1.04(0.70--1.54)
   A vs. G                                                                                          0.929                      1.01(0.86--1.18)                                                        0.658   1.04(0.88--1.23)
   HWP^a^                            0.185                    0.778                                                                                      0.78                     0.882                                
  **pri-miR-365b rs121224**                                                                                                                                                                                   
   CC                              270(31.3)                272(31.6)                                                                1.00             229(31.4)                 221(30.5)                            1.00
   CG                              428(49.7)                413(47.9)                               0.436                      0.91(0.73--1.15)       362(49.7)                 376(51.9)              0.630   1.06(0.83--1.35)
   GG                              164(19.0)                177(20.5)                               0.604                      1.08(0.81--1.43)       138(18.9)                 127(17.5)              0.806   0.96(0.70--1.32)
   CG + GG vs. CC                                                                                   0.695                      0.96(0.77--1.19)                                                        0.773   1.03(0.82--1.30)
   GG vs. CG + CC                                                                                   0.334                      1.13(0.88--1.45)                                                        0.593   0.93(0.71--1.22)
   G vs. C                                                                                          0.730                      1.03(0.89--1.18)                                                        0.963   1.00(0.86--1.16)
   HWP^a^                             0.8                      0.3                                                                                      0.811                     0.129                                
  **pri-miR4795 rs1002765**                                                                                                                                                                                   
   GG                              307(35.6)                304(35.3)                                                                1.00             262(35.9)                 272(37.6)                            1.00
   GA                              420(48.7)                416(48.3)                               0.766                      1.03(0.83--1.29)       357(49.0)                 349(48.2)              0.619   0.94(0.75--1.19)
   AA                              135(15.7)                142(16.5)                               0.654                      1.07(0.79--1.45)       110(15.1)                 103(14.2)              0.703   0.94(0.67--1.30)
   AA + GA vs. GG                                                                                   0.694                      1.04(0.85--1.28)                                                        0.590   0.94(0.76--1.17)
   AA vs. GA + GG                                                                                   0.721                      1.05(0.80--1.38)                                                        0.774   0.96(0.71--1.29)
   A vs. G                                                                                          0.638                      1.04(0.90--1.20)                                                        0.609   0.96(0.82--1.12)
   HWP^a^                            0.662                    0.988                                                                                     0.518                     0.597                                

Note: ^a^HardyWeinberg balance in the crowd.

###### Stratified analysis of pri-let-7e rs8111742, pri-miR-365b rs121224, pri-miR-4795 rs1002765 and risk of atrophic gastritis and gastric cancer.

  Variables                       Genotype      Atrophic gastritis group vs. control group        *P*            OR(95%CI)       Cancer group vs. control group      *P*           OR(95%CI)
  --------------------------- ---------------- -------------------------------------------- ---------------- ------------------ -------------------------------- ----------- ----------------------
  **pri-let7e rs8111742**                                                                                                                                                    
  *H. pylori*^a^                                              n = 862 vs 862                                   n = 724 vs 729                                                           
   Negative                          GG                          193/329                                            1.00                    196/278                                   1.00
                                     GA                          139/245                         0.814        0.97(0.74--1.27)              138/206                 0.700       0.95(0.71--1.26)
                                     AA                           25/47                          0.685        0.90(0.54--1.51)               21/44                  0.181       0.69(0.40--1.19)
                               GA + AA VS. GG                                                    0.746        0.96(0.74--1.24)                                      0.445       0.90(0.69--1.18)
                               AA VS. GA + GG                                                    0.737        0.92(0.55--1.52)                                      0.185       0.69(0.41--1.19)
   Positive                          GG                          265/130                                            1.00                    179/111                                   1.00
                                     GA                           204/96                         0.658        1.08(0.78--1.49)               153/79                 0.316       1.21(0.84--1.74)
                                     AA                           36/15                          0.641        1.16(0.62--2.21)               37/11                **0.044**   **2.09(1.02--4.26)**
                               GA + AA VS. GG                                                    0.598        1.09(0.80--1.48)                                      0.118       1.32(0.93--1.87)
                               AA VS. GA + GG                                                    0.707        1.13(0.60--2.11)                                      0.064       1.94(0.96--3.89)
  Smoking status^b^                                           n = 548 vs 586                 n = 333 vs 500                                                                  
   Smokers                           GG                           86/106                                            1.00                     72/104                                   1.00
                                     GA                           70/79                          0.566        1.14(0.73--1.80)               65/78                  0.416       1.22(0.76--1.96)
                                     AA                           17/17                          0.452        1.35(0.62--2.92)               11/17                  0.754       0.87(0.35--2.14)
                               GA + AA VS. GG                                                    0.442        1.19(0.77--1.83)                                      0.519       1.16(0.74--1.84)
                               AA VS. GA + GG                                                    0.523        1.28(0.60--2.70)                                      0.590       0.78(0.32--1.92)
   Non-smokers                       GG                          207/199                                            1.00                     98/159                                   1.00
                                     GA                          143/160                         0.213        0.81(0.59--1.13)               74/122                 0.500       0.87(0.58--1.31)
                                     AA                           25/25                          0.859        1.06(0.56--2.03)               13/20                  0.974       1.01(0.46--2.22)
                               GA + AA VS. GG                                                    0.286        0.84(0.62--1.15)                                      0.535       0.88(0.60--1.31)
                               AA VS. GA + GG                                                    0.695        1.13(0.61--2.11)                                      0.838       1.08(0.50--2.33)
  Drinking status^b^                                          n = 547 vs 585                                   n = 296 vs 499                                                           
   Drinkers                          GG                           60/74                                             1.00                     48/73                                    1.00
                                     GA                           49/63                          0.884        0.96(0.57--1.63)               51/63                  0.286       1.34(0.78--2.31)
                                     AA                           15/10                          0.161        1.87(0.78--4.51)                8/10                  0.780       1.16(0.41--3.30)
                               GA + AA VS. GG                                                    0.736        1.09(0.66--1.79)                                      0.289       1.33(0.79--2.25)
                               AA VS. GA + GG                                                    0.136        1.94(0.81--4.61)                                      0.965       0.98(0.35--2.71)
   Non-drinkers                      GG                          234/228                                            1.00                    100/187                                   1.00
                                     GA                          163/177                         0.417        0.88(0.65--1.20)               75/138                 0.388       0.84(0.56--1.25)
                                     AA                           26/33                          0.586        0.84(0.46--1.56)               14/28                  0.851       0.93(0.45--1.93)
                               GA + AA VS. GG                                                    0.371        0.87(0.65--1.17)                                      0.387       0.85(0.58--1.24)
                               AA VS. GA + GG                                                    0.675        0.88(0.49--1.58)                                      0.963       1.02(0.50--2.08)
  **pri-miR-365b rs121224**                                                                                                                                                  
  *H. pylori*^a^                                              n = 862 vs 862                                   n = 724 vs 729                                                           
   Negative                          CC                           79/118                                            1.00                     68/99                                    1.00
                                     CG                          160/304                         0.402        0.88(0.65--1.19)              182/258                 0.403       1.14(0.84--1.56)
                                     GG                          118/199                         0.492        1.14(0.79--1.64)              105/171                 0.612       1.11(0.75--1.64)
                               CG + GG VS. CC                                                    0.713        0.95(0.72--1.25)                                      0.411       1.13(0.84--1.52)
                               GG VS. CG + CC                                                    0.235        1.22(0.88--1.67)                                      0.901       1.02(0.73--1.44)
   Positive                          CC                           98/46                                             1.00                     59/39                                    1.00
                                     CG                          253/124                          0.85        0.97(0.68--1.38)              194/104                 0.806       0.95(0.64--1.42)
                                     GG                           154/71                         0.966        1.01(0.64--1.59)               116/58                 0.262       0.74(0.44--1.25)
                               CG + GG VS. CC                                                    0.886        0.98(0.70--1.37)                                      0.565       0.90(0.61--1.31)
                               GG VS. CG + CC                                                    0.915        1.02(0.69--1.51)                                      0.263       0.77(0.49--1.21)
  Smoking status^b^                                           n = 548 vs 586                 n = 333 vs 500                                                                  
   Smokers                           CC                           32/31                                             1.00                     23/30                                    1.00
                                     CG                           87/97                          0.413        1.23(0.75--1.99)               81/95                  0.273       1.34(0.80--2.24)
                                     GG                           54/74                          0.442        1.30(0.67--2.53)               44/74                  0.688       1.16(0.57--2.36)
                               CG + GG VS. CC                                                    0.371        1.23(0.78--1.95)                                      0.303       1.29(0.79--2.12)
                               GG VS. CG + CC                                                    0.576        1.18(0.66--2.10)                                      0.954       0.98(0.52--1.85)
   Non-smokers                       CC                           81/75                                             1.00                     32/63                                    1.00
                                     CG                          172/194                          0.29        0.82(0.58--1.18)              100/150                 0.402       1.21(0.77--1.90)
                                     GG                          122/115                         0.849        0.96(0.62--1.48)               53/88                  0.496       0.82(0.45--1.47)
                               CG + GG VS. CC                                                    0.387        0.86(0.62--1.21)                                      0.699       1.09(0.71--1.67)
                               GG VS. CG + CC                                                    0.745        1.07(0.72--1.57)                                      0.210       0.73(0.44--1.20)
  Drinking status^b^                                          n = 547 vs 585                 n = 296 vs 499                                                                  
   Drinkers                          CC                           25/21                                             1.00                     19/20                                    1.00
                                     CG                           64/81                          0.583        1.18(0.66--2.09)               57/81                  0.652       1.15(0.63--2.09)
                                     GG                           35/45                           0.19        1.69(0.77--3.70)               31/45                  0.305       1.54(0.68--3.51)
                               CG + GG VS. CC                                                    0.369        1.29(0.74--2.23)                                      0.497       1.22(0.69--2.17)
                               GG VS. CG + CC                                                     0.29        1.43(0.74--2.76)                                      0.365       1.39(0.68--2.83)
   Non-drinkers                      CC                           88/84                                             1.00                     30/72                                    1.00
                                     CG                          195/210                         0.393        0.86(0.62--1.21)              104/164                 0.267       1.28(0.83--1.97)
                                     GG                          140/144                         0.872        0.97(0.64--1.46)               55/117                 0.308       0.74(0.41--1.32)
                               CG + GG VS. CC                                                    0.487        0.90(0.65--1.22)                                      0.617       1.11(0.74--1.68)
                               GG VS. CG + CC                                                    0.839        1.04(0.72--1.50)                                      0.087      0.645(0.39--1.07)
  **pri-miR4795 rs1002765**                                                                                                                                                  
  *H. pylori*^a^                                              n = 862 vs 862                 n = 724 vs 729                                                                  
   Negative                          GG                          112/232                                            1.00                    130/197                                   1.00
                                     GA                          183/302                         0.108        1.27(0.95--1.70)              167/259                 0.982       1.00(0.74--1.34)
                                     AA                           62/87                          0.055        1.47(0.99--2.19)               58/72                  0.387       1.20(0.79--1.82)
                               GA + AA VS. GG                                                    0.051        1.32(1.00--1.74)                                      0.770       1.04(0.79--1.38)
                               AA VS. GA + GG                                                    0.158        1.29(0.91--1.84)                                      0.307       1.22(0.84--1.77)
   Positive                          GG                           192/75                                            1.00                     142/65                                   1.00
                                     GA                          233/118                         0.143        0.77(0.54--1.09)               182/98                 0.429       0.86(0.58--1.26)
                                     AA                           80/48                          0.129        0.70(0.45--1.11)               45/38                **0.050**   **0.58(0.34--1.00)**
                               GA + AA VS. GG                                                    0.085        0.75(0.54--1.04)                                      0.186       0.78(0.54--1.13)
                               AA VS. GA + GG                                                    0.293        0.81(0.54--1.21)                                      0.055       0.63(0.39--1.01)
  Smoking status^b^                                           n = 548 vs 586                 n = 333 vs 500                                                                  
   Smokers                           GG                           53/73                                             1.00                     60/73                                    1.00
                                     GA                           86/105                         0.517        1.18(0.72--1.93)               71/102                 0.514       0.85(0.52--1.39)
                                     AA                           34/24                          0.073        1.93(0.94--3.96)               17/24                  0.462       0.74(0.33--1.65)
                               GA + AA VS. GG                                                    0.279        1.29(0.81--2.06)                                      0.470       0.84(0.52--1.35)
                               AA VS. GA + GG                                                    0.087        1.70(0.93--3.14)                                      0.655       0.85(0.41--1.75)
   Non-smokers                       GG                          139/130                                            1.00                     62/98                                    1.00
                                     GA                          182/190                         0.705        0.94(0.66--1.32)               99/156                 0.909       0.98(0.63--1.50)
                                     AA                           54/64                          0.247        0.76(0.47--1.22)               24/47                  0.519       0.82(0.45--1.50)
                               GA + AA VS. GG                                                    0.463        0.89(0.64--1.23)                                      0.750       0.94(0.62--1.41)
                               AA VS. GA + GG                                                    0.271        0.78(0.51--1.21)                                      0.526       0.84(0.48--1.46)
  Drinking status^b^                                          n = 547 vs 585                                   n = 296 vs 499                                                           
   Drinkers                          GG                           35/47                                             1.00                     40/47                                    1.00
                                     GA                           65/76                          0.674        1.13(0.64--2.01)               51/75                  0.328       0.75(0.42--1.34)
                                     AA                           24/24                          0.334        1.46(0.68--3.17)               16/24                  0.607       0.81(0.35--1.84)
                               GA + AA VS. GG                                                    0.513        1.20(0.70--2.07)                                      0.347       0.77(0.44--1.33)
                               AA VS. GA + GG                                                    0.365        1.36(0.70--2.64)                                      0.935       0.97(0.47--2.02)
   Non-drinkers                      GG                          156/156                                            1.00                     61/124                                   1.00
                                     GA                          203/218                         0.979        1.00(0.73--1.39)              104/182                 0.650       1.10(0.72--1.68)
                                     AA                           64/64                          0.657        0.90(0.57--1.43)               24/47                  0.941       0.98(0.53--1.80)
                               GA + AA VS. GG                                                    0.893        0.98(0.72--1.33)                                      0.722       1.08(0.72--1.61)
                               AA VS. GA + GG                                                    0.639        0.91(0.60--1.37)                                      0.741       0.91(0.52--1.60)

Note: ^a^*P* values were adjusted by age and sex; ^b^*P* values were adjusted by age, sex and *H. pylori* infection status.

###### The relationship between pri-let-7e rs8111742, pri-miR-365b rs121224, pri-miR-4795 rs1002765 and the risk of intestinal type and diffuse type gastric cancer.

  Variables                    Control group   Intestinal type gastric cancer   Diffuse type gastric cancer   Intestinal type gastric cancer vs. Control group   Diffuse type gastric cancer vs. Control group          
  --------------------------- --------------- -------------------------------- ----------------------------- -------------------------------------------------- ----------------------------------------------- ------- ------------------
  **pri-let7e rs8111742**                                                                                                                                                                                               
   GG                            389(53.4)               145(53.5)                       185(50.3)                                                                                   1.00                                      1.00
   GA                            285(39.1)               107(39.5)                       146(39.7)                                 0.917                                       1.02(0.75--1.38)                  0.566   1.08(0.83--1.42)
   AA                             55(7.5)                 19(7.0)                        37(10.1)                                  0.731                                       0.90(0.51--1.62)                  0.161   1.40(0.88--2.23)
   AA + GA vs. GG                                                                                                                  0.985                                       1.00(0.75--1.34)                  0.325   1.14(0.88--1.48)
   AA vs. GA + GG                                                                                                                  0.692                                       0.89(0.50--1.58)                  0.173   1.37(0.87--2.15)
  **pri-miR-365b rs121224**                                                                                                                                                                                             
   CC                            138(18.9)                59(21.8)                       58(15.8)                                                                                    1.00                                      1.00
   CG                            362(49.7)               132(48.7)                       199(54.1)                                 0.941                                       1.01(0.72--1.42)                  0.456   1.12(0.83--1.50)
   GG                            229(31.4)                80(29.5)                       111(30.2)                                 0.336                                       1.23(0.81--1.86)                  0.477   0.87(0.59--1.29)
   CG + GG vs. CC                                                                                                                  0.665                                       1.07(0.78--1.47)                  0.731   1.05(0.79--1.39)
   GG vs. CG + CC                                                                                                                  0.283                                       1.22(0.85--1.74)                  0.232   0.81(0.57--1.14)
  **pri-miR4795 rs1002765**                                                                                                                                                                                             
   GG                            262(35.9)               101(37.3)                       142(38.6)                                                                                   1.00                                      1.00
   GA                            357(49.0)               124(45.8)                       181(49.2)                                 0.499                                       0.90(0.65--1.23)                  0.531   0.91(0.69--1.21)
   AA                            110(15.1)                46(17.0)                       45(12.2)                                  0.721                                       1.08(0.70--1.68)                  0.163   0.74(0.49--1.13)
   AA + GA vs. GG                                                                                                                  0.686                                       0.94(0.70--1.27)                  0.318   0.87(0.67--1.14)
   AA vs. GA + GG                                                                                                                  0.509                                       1.14(0.77--1.70)                  0.192   0.77(0.53--1.14)

###### Stratified analysis of pri-let-7e rs8111742, pri-miR-365b rs121224, pri-miR-4795 rs1002765 and risk of intestinal type and diffuse type gastric cancer.

  Variables                       Genotype      Control group   Intestinal type gastric cancer   Diffuse type gastric cancer   Intestinal type gastric cancer vs. control group   Diffuse type gastric cancer vs. control group              
  --------------------------- ---------------- --------------- -------------------------------- ----------------------------- -------------------------------------------------- ----------------------------------------------- ----------- --------------------------
  **pri-let7e rs8111742**                                                                                                                                                                                                                    
  *H. pylori*^a^                                                                                                                                                                                                                             
   Negative                          GG           278(52.7)                75(58.1)                       95(52.8)                                                                                    1.00                                              1.00
                                     GA           206(39.0)                49(38.0)                       69(38.3)                                  0.573                                       0.89(0.60--1.33)                    0.816         0.96(0.67--1.37)
                                     AA            44(8.3)                  5(3.9)                         16(8.9)                                  0.118                                       0.46(0.18--1.21)                    0.621         1.17(0.63--2.16)
                               GA + AA vs. GG                                                                                                       0.321                                       0.82(0.56--1.21)                    0.966         0.99(0.71--1.39)
                               AA vs. GA + GG                                                                                                       0.136                                       0.48(0.19--1.26)                    0.587         1.18(0.65--2.15)
   Positive                          GG           111(55.2)                70(49.3)                       90(47.9)                                                                                    1.00                                              1.00
                                     GA           79(39.3)                 58(40.8)                       77(41.0)                                  0.454                                       1.19(0.75--1.89)                    0.434         1.18(0.78--1.77)
                                     AA            11(5.5)                 14(9.9)                        21(11.2)                                  0.229                                       1.65(0.73--3.75)                    0.057         2.01(0.98--4.12)
                               GA + AA vs. GG                                                                                                       0.313                                       1.25(0.81--1.94)                    0.177         1.30(0.89--1.91)
                               AA vs. GA + GG                                                                                                       0.339                                       1.48(0.66--3.32)                    0.059         1.95(0.97--3.92)
  Smoking status^b^                                                                                                                                                                                                                          
   Smokers                           GG           104(52.3)                39(53.4)                       28(42.4)                                                                                    1.00                                              1.00
                                     GA           78(39.2)                 29(39.7)                       32(48.5)                                  0.972                                       1.01(0.56--1.84)                    0.113         1.65(0.89--3.06)
                                     AA            17(8.5)                  5(6.8)                         6(9.1)                                   0.666                                       0.77(0.24--2.51)                    0.409         1.61(0.52--4.95)
                               GA + AA vs. GG                                                                                                       0.914                                       0.97(0.54--1.74)                    0.085         1.69(0.93--3.08)
                               AA vs. GA + GG                                                                                                       0.612                                       0.74(0.23--2.39)                    0.628         1.30(0.45--3.80)
   Non-smokers                       GG           159(52.8)                35(53.)                        49(50.5)                                                                                    1.00                                              1.00
                                     GA           122(40.5)                27(40.9)                       39(40.2)                                  0.813                                       0.93(0.53--1.66)                    0.636         0.89(0.54--1.45)
                                     AA            20(6.6)                  4(6.1)                         9(9.3)                                   0.911                                       0.94(0.29--2.98)                    0.484         1.37(0.57--3.26)
                               GA + AA vs. GG                                                                                                       0.795                                       0.93(0.53--1.62)                    0.812         0.95(0.59--1.51)
                               AA vs. GA + GG                                                                                                       0.903                                       0.93(0.30--2.89)                    0.382         1.45(0.63--3.35)
  Drinking status^b^                                                                                                                                                                                                                         
   Drinkers                          GG           73(50.0)                 20(50.0)                       25(42.4)                                                                                    1.00                                              1.00
                                     GA           63(43.2)                 18(45.0)                       28(47.5)                                  0.638                                       1.21(0.56--2.62)                    0.254         1.46(0.76--2.81)
                                     AA            10(6.8)                  2(5.0)                         6(10.2)                                  0.565                                       0.59(0.10--3.53)                    0.354         1.71(0.55--5.35)
                               GA + AA vs. GG                                                                                                       0.743                                       1.14(0.53--2.42)                    0.185         1.53(0.82--2.88)
                               AA vs. GA + GG                                                                                                       0.557                                       0.59(0.10--3.40)                    0.531         1.42(0.47--4.25)
   Non-drinkers                      GG           187(53.0)                35(53.0)                       49(49.0)                                                                                    1.00                                              1.00
                                     GA           138(39.1)                26(39.4)                       42(42.0)                                  0.689                                       0.89(0.49--1.59)                    0.838         0.95(0.59--1.54)
                                     AA            28(7.9)                  5(7.6)                         9(9.0)                                   0.877                                       0.92(0.32--2.66)                    0.486         1.35(0.58--3.14)
                               GA + AA vs. GG                                                                                                       0.654                                       0.88(0.50--1.54)                    0.973         1.01(0.64--1.60)
                               AA vs. GA + GG                                                                                                       0.941                                       0.96(0.34--2.75)                    0.399         1.42(0.63--3.20)
  **pri-miR-365b rs121224**                                                                                                                                                                                                                  
  *H. pylori*^a^                                                                                                                                                                                                                             
   Negative                          CC           171(32.4)                36(27.9)                       51(28.3)                                                                                    1.00                                              1.00
                                     CG           258(48.9)                62(48.1)                       96(53.3)                                  0.621                                       1.12(0.71--1.77)                    0.250         1.26(0.85--1.85)
                                     GG           99(18.8)                 31(24.0)                       33(18.3)                                  0.144                                      0.50(0.87--2.57)\_                   0.699         1.10(0.67--1.82)
                               CG + GG vs. CC                                                                                                       0.348                                       1.23(0.80--1.88)                    0.314         1.21(0.84--1.75)
                               GG vs. CG + CC                                                                                                       0.147                                       1.41(0.89--2.23)                    0.837         0.96(0.62--1.47)
   Positive                          CC           58(28.9)                 44(31.0)                       60(31.9)                                                                                    1.00                                              1.00
                                     CG           104(51.7)                70(49.3)                       103(54.8)                                 0.663                                       0.90(0.54--1.47)                    0.969         0.99(0.64--1.53)
                                     GG           39(19.4)                 28(19.7)                       25(13.3)                                  0.779                                       0.91(0.48--1.75)                    0.157         0.65(0.36--1.18)
                               CG + GG vs. CC                                                                                                       0.665                                       0.90(0.56--1.45)                    0.617         0.90(0.59--1.36)
                               GG vs. CG + CC                                                                                                       0.996                                       1.00(0.58--1.73)                    0.121         0.66(0.39--1.12)
  Smoking status^b^                                                                                                                                                                                                                          
   Smokers                           CC           74(37.2)                 20(27.4)                       19(28.8)                                                                                    1.00                                              1.00
                                     CG           95(47.7)                 38(52.1)                       39(259.1)                                 0.411                                       1.32(0.68--2.56)                    0.340         1.39(0.71--2.70)
                                     GG           30(15.1)                 15(20.5)                        8(12.1)                                  0.475                                       1.33(0.61--2.87)                    0.948         0.97(0.37--2.55)
                               CG + GG vs. CC                                                                                                       0.328                                       1.37(0.73--2.58)                    0.424         1.30(0.68--2.46)
                               GG vs. CG + CC                                                                                                       0.512                                       1.28(0.61--2.69)                    0.625         0.81(0.34--1.92)
   Non-smokers                       CC           88(29.2)                 19(28.8)                       28(28.9)                                                                                    1.00                                              1.00
                                     CG           150(49.8)                30(45.5)                       56(57.7)                                  0.956                                       1.02(0.53--1.95)                                          
                                     GG           63(20.9)                 17(25.8)                       13(13.4)                                  0.361                                       1.50(0.63--3.59)                    0.317         0.68(0.32--1.44)
                               CG + GG vs. CC                                                                                                       0.755                                       1.10(0.60--2.03)                    0.742         1.09(0.65--1.82)
                               GG vs. CG + CC                                                                                                       0.430                                       1.29(0.68--2.45)                    0.109         0.58(0.30--1.13)
  Drinking status^b^                                                                                                                                                                                                                         
   Drinkers                          CC           45(30.8)                 8(20.0)                        21(35.6)                                                                                    1.00                                              1.00
                                     CG           81(55.0)                 21(52.5)                       30(50.8)                                  0.288                                       1.69(0.64--4.46)                    0.706         0.88(0.44--1.74)
                                     GG           20(13.7)                 11(27.5)                        8(13.6)                                **0.029**                                 **3.76(1.15**--**12.34)**               0.756         0.85(0.32--2.31)
                               CG + GG vs. CC                                                                                                       0.131                                       2.02(0.81--5.05)                    0.688         0.87(0.45--1.69)
                               GG vs. CG + CC                                                                                                     **0.045**                                 **2.52(1.02**--**6.23)**                0.833         0.91(0.37--2.23)
   Non-drinkers                      CC           117(33.1)                20(30.3)                       26(26.0)                                                                                    1.00                                              1.00
                                     CG           164(45.6)                30(45.5)                       62(62.0)                                  0.978                                       0.99(0.52--1.88)                    0.104         1.56(0.91--2.66)
                                     GG           72(20.4)                 16(24.2)                       12(12.0)                                  0.861                                       1.07(0.49--2.35)                    0.407         0.72(0.34--1.56)
                               CG + GG vs. CC                                                                                                       0.933                                       1.03(0.56--1.87)                    0.302         1.31(0.78--2.19)
                               GG vs. CG + CC                                                                                                       0.781                                       1.10(0.57--2.13)                    0.073         0.54(0.27--1.06)
  **pri-miR4795 rs1002765**                                                                                                                                                                                                                  
  *H. pylori*^a^                                                                                                                                                                                                                             
   Negative                          GG           197(37.3)                49(38.0)                       66(36.7)                                                                                    1.00                                              1.00
                                     GA           259(49.1)                58(45.0)                       86(47.8)                                  0.898                                       0.97(0.64--1.49)                    0.882         1.03(0.71--1.48)
                                     AA           72(13.6)                 22(17.1)                       28(15.6)                                  0.422                                       1.27(0.71--2.24)                    0.712         1.10(0.66--1.85)
                               GA + AA vs. GG                                                                                                       0.850                                       1.04(0.70--1.55)                    0.809         1.04(0.74--1.48)
                               AA vs. GA + GG                                                                                                       0.319                                       1.31(0.77--2.20)                    0.685         1.10(0.69--1.76)
   Positive                          GG           65(32.3)                 52(36.6)                       76(40.4)                                                                                    1.00                                              1.00
                                     GA           98(48.8)                 66(46.5)                       95(50.5)                                  0.337                                       0.79(0.49--1.28)                    0.295         0.80(0.53--1.22)
                                     AA           38(18.9)                 24(16.9)                        17(9.0)                                  0.504                                       0.80(0.41--1.56)                  **0.005**   **0.39(0.20**--**0.75)**
                               GA + AA vs. GG                                                                                                       0.317                                       0.79(0.50--1.25)                    0.062         0.68(0.46--1.02)
                               AA vs. GA + GG                                                                                                       0.771                                       0.92(0.52--1.63)                  **0.005**   **0.43(0.24**--**0.78)**
  Smoking status^b^                                                                                                                                                                                                                          
   Smokers                           GG           73(36.7)                 29(39.7)                       28(42.4)                                                                                    1.00                                              1.00
                                     GA           102(51.3)                32(43.8)                       34(51.5)                                  0.492                                       0.80(0.43--1.51)                    0.454         0.78(0.41--1.48)
                                     AA           24(12.1)                 12(16.4)                        4(6.1)                                   0.986                                       0.99(0.39--2.51)                    0.057         0.29(0.08--1.04)
                               GA + AA vs. GG                                                                                                       0.648                                       0.87(0.48--1.59)                    0.258         0.70(0.38--1.30)
                               AA vs. GA + GG                                                                                                       0.785                                       1.12(0.49--2.58)                    0.153         0.43(0.14--1.37)
   Non-smokers                       GG           98(32.6)                 23(34.8)                       32(33.0)                                                                                    1.00                                              1.00
                                     GA           156(51.8)                34(51.5)                       52(53.6)                                  0.924                                       1.03(0.56--1.89)                    0.692         1.11(0.66--1.87)
                                     AA           47(15.6)                 9(13.6)                        13(13.4)                                   0.58                                       0.78(0.33--1.86)                    0.438         0.75(0.35--1.57)
                               GA + AA vs. GG                                                                                                       0.889                                       0.96(0.54--1.71)                    0.941         1.02(0.62--1.67)
                               AA vs. GA + GG                                                                                                       0.496                                       0.76(0.35--1.66)                    0.308         0.71(0.36--1.38)
  Drinking status^b^                                                                                                                                                                                                                         
   Drinkers                          GG           47(32.2)                 9(22.5)                        28(47.5)                                                                                    1.00                                              1.00
                                     GA           75(51.4)                 21(52.5)                       26(44.1)                                  0.428                                       1.45(0.58--3.65)                    0.070         0.53(0.27--1.05)
                                     AA           24(16.4)                 10(25.0)                        5(8.5)                                   0.187                                       2.19(0.68--7.03)                    0.069         0.35(0.11--1.09)
                               GA + AA vs. GG                                                                                                       0.270                                       1.65(0.68--3.99)                  **0.032**   **0.49(0.25**--**0.94)**
                               AA vs. GA + GG                                                                                                       0.274                                       1.68(0.66--4.26)                    0.232         0.53(0.19--1.51)
   Non-drinkers                      GG           124(35.1)                24(36.4)                       30(30.0)                                                                                    1.00                                              1.00
                                     GA           182(51.6)                32(48.5)                       58(58.0)                                  0.931                                       0.97(0.53--1.79)                    0.308         1.31(0.78--2.20)
                                     AA           47(13.3)                 10(15.2)                       12(12.0)                                  0.857                                       0.92(0.39--3.19)                    0.661         0.84(0.39--1.81)
                               GA + AA vs. GG                                                                                                       0.900                                       0.96(0.54--1.72)                    0.472         1.20(0.73--1.97)
                               AA vs. GA + GG                                                                                                       0.844                                       0.93(0.43--1.99)                    0.314         0.70(0.35--1.40)

Note: ^a^*P* values were adjusted by age and sex; ^b^*P* values were adjusted by age, sex and *H. pylori* infection status.

###### Correlation between pri-let-7e rs8111742, pri-miR-365b rs121224, pri-miR-4795 rs1002765 polymorphism and clinical pathological parameters.

  Clinical pathological parameters    Case number   Genotype    Dominant model *P*   Recessive model *P*          
  ---------------------------------- ------------- ----------- -------------------- --------------------- ------- --------------
  **pri-let7e rs8111742**                 357                                                                            
  Age                                                                                                      0.113      0.802
   ≤60                                    168       73(43.5)         82(48.8)              13(7.7)                       
   \>60                                   189       98(51.9)         75(39.7)              16(8.5)                       
  Gender                                                                                                   0.228      0.902
   Male                                   255       117(45.9)       117(45.9)              21(8.2)                       
   Female                                 102       54(52.9)         40(39.2)              8(7.8)                        
  Borrmann type                                                                                            0.850      0.564
   Borrmann I--II                         83        39(47.0)         36(43.4)              8(9.6)                        
   Borrmann III--IV                       274       132(48.2)       121(44.2)              21(7.7)                       
  Lauren type                                                                                              0.064      0.138
   Intestinal type                        120       66(55.0)         48(40.0)              6(5.0)                        
   Diffuse type                           231       103(44.6)       106(45.9)              22(9.5)                       
   Non classified carcinoma                6         2(33.3)         3(50.0)               1(16.7)                       
  TNM staging                                                                                              0.280      0.131
   I--II                                  171       87(50.9)         74(43.3)              10(5.8)                       
   III--IV                                186       84(45.2)         83(44.6)             19(10.2)                       
  Depth of invasion                                                                                        0.989      0.652
   T1 + T2                                98        47(48.0)         42(42.9)              9(9.2)                        
   T3 + T4                                259       124(47.9)       115(44.4)              20(7.7)                       
  Lymph node metastasis                                                                                    0.325      0.121
   Positive                               216       98(45.4)         95(44.0)             23(10.6)                       
   Negative                               141       73(51.8)         62(44.0)              6(4.3)                        
  **pri-miR-365b rs121224**               347                                                                            
  Age                                                                                                      0.647      0.507
   ≤60                                    163       47(28.8)         85(52.1)             31(19.0)                       
   \>60                                   184       49(26.6)        105(57.1)             30(16.3)                       
  Gender                                                                                                   0.193      0.809
   Male                                   249       64(25.7)        142(57.0)             43(17.3)                       
   Female                                 98        32(32.7)         48(49.0)             18(18.4)                       
  Borrmann type                                                                                            0.393      0.235
   Borrmann I--II                         83        26(31.3)         46(55.4)             11(13.3)                       
   Borrmann III--IV                       264       70(26.5)        144(54.5)             50(18.9)                       
  Lauren type                                                                                              0.329   **0.014**^b^
   Intestinal type                        118       36(30.5)         53(44.9)             29(24.6)                       
   Diffuse type                           223       57(25.6)        135(60.5)             31(13.9)                       
   Non classified carcinoma                6                                                                             
  TNM staging                                                                                              0.961   **0.031**^c^
   I--II                                  167       46(27.5)         84(50.3)             37(22.2)                       
   III--IV                                180       50(27.8)        106(58.9)             24(13.3)                       
  Depth of invasion                                                                                        0.976      0.809
   T1 + T2                                98        27(27.6)         53(54.1)             18(18.4)                       
   T3 + T4                                249       69(27.7)        137(55.0)             43(17.3)                       
  Lymph node metastasis                                                                                    0.237      0.624
   Positive                               210       56(26.7)        120(57.1)             34(16.2)                       
   Negative                               137       40(29.2)         70(51.1)             27(19.7)                       
  **pri-mir4795 rs1002765**               357                                                                            
  Age                                                                                                      0.170      0.240
   ≤60                                    168       65(38.7)         82(48.8)             21(12.5)                       
   \>60                                   189       60(31.7)         97(51.3)             32(16.9)                       
  Gender                                                                                                   0.160      0.541
   Male                                   255       95(37.3)        124(48.6)             36(14.1)                       
   Female                                 102       30(29.4)         55(53.9)             17(16.7)                       
  Borrmann type                                                                                            0.064      0.345
   Borrmann I--II                         83        22(26.5)         46(55.4)             15(18.1)                       
   Borrmann III--IV                       274       103(37.6)       133(48.5)             38(13.9)                       
  Lauren type                                                                                              0.823      0.782
   Intestinal type                        120       43(35.8)         58(48.3)             19(15.8)                       
   Diffuse type                           231       80(34.6)        117(50.6)             34(14.7)                       
   Non classified carcinoma                6         2(33.3)         4(66.6)               0(0.0)                        
  TNM staging                                                                                              0.846      0.908
   I--II                                  171       59(34.5)         87(50.9)             25(14.6)                       
   III--IV                                186       66(35.5)         92(49.5)             28(15.1)                       
  Depth of invasion                                                                                        0.565      0.880
   T1 + T2                                98        32(32.7)         51(52.0)             15(15.3)                       
   T3 + T4                                259       93(35.9)        128(49.4)             38(14.7)                       
  Lymph node metastasis                                                                                    0.753      0.916
   Positive                               216       75(34.7)        109(50.5)             32(14.8)                       
   Negative                               141       50(35.5)         70(49.6)             21(14.9)                       

Note: a, using chi square test; b, a multivariate regression analysis was used to correct for age and sex factors *P* = 0.014, OR = 1.42, 95%CI = 0.87--2.47; c, a multivariate regression analysis was used to correct for age and sex factors *P* = 0.031, OR = 1.37, 95%CI = 1.03--1.82.

###### Relationship between miRNAs polymorphism and prognosis of gastric cancer in different subgroups.

  Clinical pathological parameters    Genotype (death/total)   Dominant model   Recessive model                                          
  ---------------------------------- ------------------------ ---------------- ----------------- ------- ------------------- ----------- --------------------
  **pri-let7e rs8111742**                                                                                                                
  Age                                                                                                                                    
   ≤60                                        19/82                18/71              3/9         0.670   1.15(0.62--2.13)      0.389      1.51(0.59--3.86)
   \>60                                       29/100               16/72             2/15         0.854   0.95(0.54--1.67)      0.608      1.27(0.51--3.22)
  Gender                                                                                                                                 
   Male                                       36/131               25/109            1/14         0.902   0.97(0.59--1.59)      0.612      1.24(0.54--2.89)
   Female                                     12/53                10/39             4/10         0.539   1.27(0.59--2.76)      0.380      1.61(0.56--4.69)
  Borrmann type                                                                                                                          
   Borrmann I--II                             13/37                10/31              0/5         0.140   0.53(0.23--1.23)      0.464      1.58(0.47--5.32)
   Borrmann III--IV                           35/128               23/99             5/18         0.230   1.35(0.83--2.20)      0.450      1.35(0.62--2.96)
  Lauren type                                                                                                                            
   Intestinal type                            14/69                10/53              2/7         0.512   0.75(0.32--1.76)      0.435     0.05(0.00--105.98)
   Diffuse type                               32/112               24/93             3/17         0.485   1.20(0.72--2.01)      0.079      1.84(0.93--3.62)
  TNM staging                                                                                                                            
   I--II                                      20/91                11/75             0/10         0.052   0.22(0.05--1.01)      0.510     0.04(0.00--484.52)
   II--IV                                     28/93                24/73             5/14         0.573   1.14(0.73--1.79)      0.298      1.42(0.73--2.77)
   Depth of invasion                           0/43                 1/34              0/7         0.591   0.52(0.05--5.71)      0.653             NA
   T1 + T2                                    32/102               25/87             5/13         0.715   1.08(0.71--1.65)      0.071      1.84(0.95--3.56)
   T3 + T4                                                                                                                               
  Lymph node metastasis                                                                                                                  
   Positive                                   38/110               32/88             5/15         0.610   1.12(0.72--1.76)      0.593      1.20(0.62--2.33)
   Negative                                   10/74                 2/59              0/9         0.141   0.38(0.10--1.39)      0.611             NA
  **pri-miR-365b rs121224**                                                                                                              
  Age                                                                                                                                    
   ≤60                                        13/43                23/83             3/31         0.522   0.82(0.45--1.51)      0.066      0.33(0.10--1.08)
   \>60                                       15/48                26/104            6/30         0.473   0.79(0.41--1.51)      0.457      0.72(0.31--1.70)
  Gender                                                                                                                                 
   Male                                       20/63                36/142            6/43         0.246   0.73(0.43--1.24)      0.087      0.48(0.21--1.11)
   Female                                      9/32                13/48             3/18         0.930   0.96(0.43--2.19)      0.448      0.63(0.19--2.10)
  Borrmann type                                                                                                                          
   Borrmann I--II                             10/25                11/39              2/9         0.172   0.56(0.25--1.28)      0.703      0.75(0.18--3.22)
   Borrmann III--IV                           18/59                37/129            7/47         0.686   0.90(0.53--1.53)    **0.042**    0.44(0.20--0.97)
  Lauren type                                                                                                                            
   Intestinal type                             9/38                15/59             2/30         0.626   0.82(0.36--1.85)    **0.031**    0.20(0.05--0.86)
   Diffuse type                               18/54                34/130            6/30         0.486   0.82(0.47--1.43)      0.577      0.79(0.34--1.83)
  TNM staging                                                                                                                            
   I--II                                      13/52                15/83             3/34         0.065   0.34(0.11--1.07)      0.296      0.34(0.04--2.60)
   III--IV                                    16/43                34/107            6/27         0.917   1.03(0.63--1.68)      0.458      0.76(0.36--1.58)
  Depth of invasion                                                                                                                      
   T1 + T2                                     1/21                 0/46             0/17         0.203   0.21(0.02--2.32)      0.607             NA
   T3 + T4                                    17/46                37/109            7/37         0.428   0.83(0.53--1.31)      0.088      0.55(0.28--1.10)
  Lymph node metastasis                                                                                                                  
   Positive                                   22/54                44/119            8/34         0.833   0.95(0.58--1.55)      0.164      0.59(0.29--1.24)
   Negative                                    6/40                 5/71             1/27         0.067   0.35(0.11--1.08)      0.346      0.37(0.05--2.89)
  **pri-mir4795 rs1002765**                                                                                                              
  Age                                                                                                                                    
   ≤60                                        14/64                21/79             5/19         0.952   1.02(0.53--1.95)      0.771      0.87(0.34--2.22)
   \>60                                       17/58                19/96             11/32        0.258   0.71(0.39--1.28)      0.351      1.38(0.70--2.70)
  Gender                                                                                                                                 
   Male                                       23/95                28/123            11/35        0.528   0.85(0.51--1.42)      0.531      1.23(0.64--2.36)
   Female                                     42246                13/55             5/17         0.594   0.80(0.35--1.84)      0.963      0.98(0.37--2.60)
  Borrmann type                                                                                                                          
   Borrmann I--II                              7/17                10/41             6/15         0.711   0.91(0.55--1.50)      0.337      1.58(0.62--4.00)
   Borrmann III--IV                           23/91                30/120            10/33        0.509   0.74(0.31--1.80)      0.936      1.03(0.52--2.02)
  Lauren type                                                                                                                            
   Intestinal type                             9/45                13/64             4/19         0.693   0.85(0.37--1.92)      0.851      0.90(0.31--2.63)
   Diffuse type                               22/79                25/110            12/33        0.279   0.75(0.44--1.27)      0.411      1.30(0.69--2.45)
  TNM staging                                                                                                                            
   I--II                                       7/55                16/92             8/28         0.254   2.42(0.53--11.05)     0.417      1.72(0.46--6.38)
   III--IV                                    24/70                25/86             8/24         0.078   0.66(0.41--1.05)      0.897      1.04(0.57--1.89)
  Depth of invasion                                                                                                                      
   T1 + T2                                     1/29                 0/44             0/11         0.211   0.22(0.02--2.38)      0.626             NA
   T3 + T4                                    23/77                30/98             9/26         0.598   0.89(0.57--1.39)      0.507      1.20(0.70--2.07)
  Lymph node metastasis                                                                                                                  
   Positive                                   29/75                33/107            13/31        0.086   0.67(0.42--1.06)      0.734      1.11(0.61--2.01)
   Negative                                    2/50                 7/70             3/21         0.232   2.53(0.55--11.54)     0.503      1.57(0.42--5.81)

HR, hazard rate; NA, not avalable.

[^1]: These authors contributed equally to this work.
